The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in favor of the approval of AGAMREE® (vamorolone) for the treatment of DMD patients aged 4 years and older. Duchenne Muscular Dystrophy (DMD) is a rare neuromuscular condition. DMD has a high unmet medical need for an effective and well-tolerated treatment … Continue reading Europe’s CHMP Issues Positive Opinion For Santhera’s AGAMREE® (vamorolone) To Treat Duchenne Muscular Dystrophy